Bio-View Ltd
TLV: BIOV.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Daniel Klain
- Employees
- 33
- Headquarters
- Rehovot, Israel
- IPO year
- 2006
- Market cap
- ILA 22.4M
- Website
- https://www.bioview.com
Loading BIOV…
Loading profile data…Frequently asked questions about BIOV
What does Bio-View Ltd (BIOV.TA) do?
Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. Its products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic...
Where does BIOV.TA trade?
Bio-View Ltd (BIOV.TA) trades on the Tel Aviv Stock Exchange.
What sector is BIOV.TA in?
Bio-View Ltd (BIOV.TA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Bio-View Ltd?
Daniel Klain is the chief executive officer of Bio-View Ltd (BIOV.TA).
Where is Bio-View Ltd headquartered?
Bio-View Ltd is headquartered in Israel.
Does BIOV.TA pay a dividend?
Bio-View Ltd (BIOV.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOV.TA go public?
Bio-View Ltd (BIOV.TA) completed its initial public offering in 2006.